BSP takes cardiac monitoring technology to Korean market
This article was originally published in Clinica
Executive Summary
Marking the second Asian distribution deal for its HyperQ ischaemic heart disease diagnostic system, Israeli firm BSP (Biological Signal Processing) has enlisted CMP Trading as its exclusive distributor for the South Korean market.